Compare LINK & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINK | XLO |
|---|---|---|
| Founded | 1984 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 56.9M |
| IPO Year | 2007 | 2021 |
| Metric | LINK | XLO |
|---|---|---|
| Price | $3.19 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 21.7K | 14.4K |
| Earning Date | 11-16-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.83 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $11,890,000.00 | ★ $43,766,000.00 |
| Revenue This Year | $40.45 | N/A |
| Revenue Next Year | $19.16 | $23.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.81 | ★ 589.88 |
| 52 Week Low | $2.66 | $0.46 |
| 52 Week High | $6.50 | $23.49 |
| Indicator | LINK | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 26.80 | 50.12 |
| Support Level | $2.87 | $7.29 |
| Resistance Level | $3.38 | $9.35 |
| Average True Range (ATR) | 0.30 | 0.74 |
| MACD | -0.08 | 0.08 |
| Stochastic Oscillator | 12.01 | 71.00 |
Interlink Electronics Inc is a provider of sensing technologies and printed electronics solutions that enable Human-Machine Interface (HMI) devices and Internet-of-Things (IoT) applications. Its broad product and technology portfolio spans force and touch sensors, piezoelectric sensors, rugged HMI sensors, wearable and textile-based sensors and electrochemical gas and environmental sensors, along with instruments and fully integrated systems based on its sensor technologies. It serves blue-chip customers and emerging companies across diverse end-use markets, including medical, industrial, automotive, consumer electronics, wearables, environmental monitoring, and specialty applications. It operates in single segment: the design, development, and manufacture of sensor technologies.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.